LUDWIG INSTITUTE FOR CANCER RESEARCH LTD;PARACRINE THERAPEUTICS AB
发明人:
ERIKSSON, ULF,LI, HONG,SCOTT, ANDREW,ALLAN, LAURA
申请号：
CA3029332
公开号：
CA3029332A1
申请日:
2017.06.30
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present invention relates, in part, to isolated antibodies that specifically interact with and show measurable binding affinity to an epitope of platelet derived growth factor C (PDGF-C). Such antibodies may be used for the modulation of PDGF-C activity in or secreted from a cell to study its effects on cell function and, in certain embodiments, for the treatment and/or prevention of a disease or condition associated with PDGF-C signing pathway.
